The scientist’s investigation covers issues in Anesthesia, Epilepsy, Adverse effect, Clinical trial and Anticonvulsant. His Anesthesia study combines topics from a wide range of disciplines, such as Gabapentin and Central nervous system disease. Epilepsy is frequently linked to Pediatrics in his study.
His Clinical trial research incorporates elements of Placebo and Randomized controlled trial. Ahmad Beydoun interconnects Peripheral neuropathy, McGill Pain Questionnaire, Diabetic neuropathy and Profile of mood states in the investigation of issues within Placebo. Ahmad Beydoun has included themes like Tolerability and Internal medicine in his Oxcarbazepine study.
Ahmad Beydoun mainly investigates Epilepsy, Anesthesia, Electroencephalography, Pediatrics and Clinical trial. His Epilepsy research incorporates themes from Tolerability, Adverse effect and Internal medicine. His Anesthesia research is multidisciplinary, incorporating perspectives in Gabapentin, Carbamazepine, Oxcarbazepine and Status epilepticus.
His Gabapentin research includes elements of Analgesic and Refractory. The concepts of his Clinical trial study are interwoven with issues in Placebo and Randomized controlled trial. His research in the fields of Electrophysiology and Stimulus overlaps with other disciplines such as Laser-Evoked Potentials.
His primary scientific interests are in Epilepsy, Electroencephalography, Anesthesia, Pediatrics and Internal medicine. He is interested in Temporal lobe, which is a field of Epilepsy. The Electroencephalography study combines topics in areas such as Rhythm, Neuroimaging, Polysomnography, Melatonin and Sedation.
His work deals with themes such as Epileptic encephalopathy, Early myoclonic encephalopathy, Refractory seizures, Psychomotor learning and Seizure frequency, which intersect with Anesthesia. As a part of the same scientific study, Ahmad Beydoun usually deals with the Pediatrics, concentrating on Seizure types and frequently concerns with Focal motor seizures and Case report form. His study on Prospective cohort study, Tolerability and Vomiting is often connected to In patient as part of broader study in Internal medicine.
The scientist’s investigation covers issues in Pediatrics, Internal medicine, Discontinuation, Adverse effect and Nausea. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Epilepsy. His research in Epilepsy intersects with topics in Severity of illness and Cardiovascular risk factors.
His Adverse effect study incorporates themes from Desmopressin, Vomiting and Lacosamide. His work often combines Troponin T and Anesthesia studies. Ahmad Beydoun combines subjects such as Young adult and Cardiology with his study of Anesthesia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: A Randomized Controlled Trial
Miroslav Backonja;Ahmad Beydoun;Keith R. Edwards;Sherwyn L. Schwartz.
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
J. A. French;A. M. Kanner;J. Bautista;B. Abou-Khalil.
Cerebral processing of acute skin and muscle pain in humans.
Peter Svensson;Satoshi Minoshima;Ahmad Beydoun;Thomas J. Morrow;Thomas J. Morrow.
Journal of Neurophysiology (1997)
Variability of laser-evoked potentials: attention, arousal and lateralized differences
Ahmad A. Beydoun;Ahmad A. Beydoun;Thomas J. Morrow;Thomas J. Morrow;Joanne F. Shen;Joanne F. Shen;Kenneth L. Casey;Kenneth L. Casey.
Electroencephalography and Clinical Neurophysiology (1993)
Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy
A. Beydoun;B. M. Uthman;A. R. Kugler;M. J. Greiner.
Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial
Ahmad Beydoun;R. C. Sachdeo;W. E. Rosenfeld;G. L. Krauss.
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy
Ekrem Kutluay;Kevin McCague;Joseph D’Souza;Ahmad Beydoun.
Epilepsy & Behavior (2003)
Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
Ahmad Beydoun;Joseph D'Souza;David Hebert;Pamela Doty.
Expert Review of Neurotherapeutics (2009)
Valproate-induced thrombocytopenia: a prospective monotherapy study
Wassim Nasreddine;Ahmad Beydoun.
Safety and Efficacy of Divalproex Sodium Monotherapy in Partial Epilepsy: A Double-blind, Concentration-response Design Clinical Trial
A. Beydoun;J. C. Sackellares;V. Shu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: